drugset / Trial / NCT01105377

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

NCT01105377

Phase 2 Completed 47 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well giving azacitidine together with entinostat works in treating patients with metastatic colorectal cancer. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Entinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving azacitidine together with entinostat may kill more tumor cells.

Timeline

Start
2010-04
Primary completion
2012-03
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Azacitidine Other / unclassified Subcutaneous
Subject Entinostat Small molecule Oral

Indications